Search results (373)
« Back to PublicationsHigh-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.
Journal article
Parker H. et al, (2026), Leukemia, 40, 816 - 826
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.
Journal article
Chamba C. et al, (2026), Nat Med
Outcomes and Risk Factors for Complications of Dermis-Fat Graft as Primary Orbital Implant.
Journal article
Schuh A. et al, (2026), Ophthalmic Plast Reconstr Surg, 42, 162 - 167
Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania.
Journal article
Jiang J. et al, (2026), BMC Med, 24
Media coverage and PATHFINDER2: hype, simplification, and free advertising.
Journal article
Turnbull C. et al, (2026), Lancet Oncol, 27, 144 - 145
A call to standardize the definition of countries with a high-burden of sickle cell disease
Journal article
Seabold A. et al, (2026), Journal of Sickle Cell Disease, 3
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.
Journal article
Walewska R. et al, (2025), Br J Haematol, 207, 2296 - 2313
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.
Journal article
Domenico D. et al, (2025), Nat Commun, 16
Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.
Journal article
Lutz C. et al, (2025), Sci Rep, 15
Evidence of latent-lytic replication in EBV-positive Burkitt lymphoma from whole genome and transcriptome sequencing
Preprint
Legason I. et al, (2025)
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Journal article
Munir T. et al, (2025), N Engl J Med, 393, 1177 - 1190
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.
Journal article
Zeisig BB. et al, (2025), Blood, 146, 1314 - 1330
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment.
Journal article
Bola S. et al, (2025), Eur J Cancer, 227
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
Journal article
Ward JC. et al, (2025), J Pathol, 267, 40 - 55
Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma
Preprint
Chamba C. et al, (2025)